A Randomized Clinical Trial to Evaluate the Efficacy of an Oral Probiotic in Acne Vulgaris
Acta Dermato-Venereologica · 15.05.2024 · 104 · adv33206
DOI: 10.2340/actadv.v104.33206 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Acta Dermato-Venereologica, online erschienen am 15.05.2024. Verfasst von Cristina Eguren und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Eguren Dermatology and Aesthetics Clinic, Madrid, Spain. Hauptthemen laut MEDLINE: Probiotics, Acne Vulgaris, Lacticaseibacillus rhamnosus. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The relevance of the gut microbiota in some skin inflammatory diseases, including acne vulgaris, has been emphasized. Probiotics could play a role in the modulation of the microbiota, improving the clinical course of this disease. A 12-week randomized, double-blind, placebo-controlled, clinical trial with patients aged 12 to 30 years with acne vulgaris was conducted. The study product was a capsule composed of the probiotic Lacticaseibacillus rhamnosus (CECT 30031) and the cyanobacterium Arthrospira platensis (BEA_IDA_0074B). Patients with improvement in the Acne Global Severity Scale were 10/34 (29.41%) in the placebo group compared with 20/40 (50%) in the probiotic group (p = 0.03). A significant reduction (p = 0.03) in the number of non-inflammatory acne lesions was observed in the probiotic group (–18.60 [–24.38 to –12.82]) vs the placebo group (–10.54 [–17.43 to –3.66]). Regarding the number of total lesions, a reduction almost reaching statistical significance (p = 0.06) was observed in the probiotic group (–27.94 [–36.35 to –19.53]) compared with the placebo group (–18.31 [–28.21 to –8.41]). In addition, patients with improvement attending the Global Acne Grading System were 7/34 (20.58%) in the placebo group vs 17/40 (42.50%) in the probiotic group (p = 0.02). The number of adverse events was similar in both groups. The probiotic used in this study was effective and well tolerated, and it should be considered for acne vulgaris patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Eguren Dermatology and Aesthetics Clinic, Madrid, Spain.
- Department of Dermatology, Dermatological and Aesthetic Center, Alicante, Spain.
- Department of Dermatology, University Hospital Sagrat Cor, Barcelona, Spain.
- Faculty of Medicine, University of Alcalá de Henares, Madrid, Spain.
- Faculty of Medicine, Catholic University of Murcia (UCAM), Murcia, Spain.
- Faculty of Medicine, Catholic University of Murcia (UCAM), Murcia, Spain; Department of Internal Medicine, University Hospital Vinalopó-Fisabio, Elche, Spain. vicente.navarro@bioithas.com.
Zitieren
APA
Eguren, C., Navarro-Blasco, A., Corral-Forteza, M., Reolid-Pérez, A., Setó-Torrent, N., García-Navarro, A., Prieto-Merino, D., Núñez-Delegido, E., Sánchez-Pellicer, P., & Navarro-López, V. (2024). A Randomized Clinical Trial to Evaluate the Efficacy of an Oral Probiotic in Acne Vulgaris. Acta Dermato-Venereologica, 104, adv33206. https://doi.org/10.2340/actadv.v104.33206
Vancouver
Eguren C, Navarro-Blasco A, Corral-Forteza M, Reolid-Pérez A, Setó-Torrent N, García-Navarro A, et al. A Randomized Clinical Trial to Evaluate the Efficacy of an Oral Probiotic in Acne Vulgaris. Acta Dermato-Venereologica. 2024;104:adv33206. doi:10.2340/actadv.v104.33206
BibTeX
@article{Eguren2024,
author = {Eguren, Cristina and Navarro-Blasco, Ariadna and Corral-Forteza, Marina and Reolid-Pérez, Alejandra and Setó-Torrent, Núria and García-Navarro, Alejandro and Prieto-Merino, David and Núñez-Delegido, Eva and Sánchez-Pellicer, Pedro and Navarro-López, Vicente},
title = {A Randomized Clinical Trial to Evaluate the Efficacy of an Oral Probiotic in Acne Vulgaris},
journal = {Acta Dermato-Venereologica},
year = {2024},
volume = {104},
pages = {adv33206},
doi = {10.2340/actadv.v104.33206}
}
EUVIMED